These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
342 related articles for article (PubMed ID: 34644216)
21. Construction of a novel choline metabolism-related signature to predict prognosis, immune landscape, and chemotherapy response in colon adenocarcinoma. Liu C; Liu D; Wang F; Liu Y; Xie J; Xie J; Xie Y Front Immunol; 2022; 13():1038927. PubMed ID: 36451813 [TBL] [Abstract][Full Text] [Related]
22. A Novel Pyroptosis-Related Gene Signature for Predicting the Prognosis and the Associated Immune Infiltration in Colon Adenocarcinoma. Chen Z; Han Z; Nan H; Fan J; Zhan J; Zhang Y; Zhu H; Cao Y; Shen X; Xue X; Lin K Front Oncol; 2022; 12():904464. PubMed ID: 35912258 [TBL] [Abstract][Full Text] [Related]
23. Prognostic implications of ferroptosis-associated gene signature in colon adenocarcinoma. Miao YD; Kou ZY; Wang JT; Mi DH World J Clin Cases; 2021 Oct; 9(29):8671-8693. PubMed ID: 34734046 [TBL] [Abstract][Full Text] [Related]
24. An Intratumor Heterogeneity-Related Signature for Predicting Prognosis, Immune Landscape, and Chemotherapy Response in Colon Adenocarcinoma. Liu C; Liu D; Wang F; Xie J; Liu Y; Wang H; Rong J; Xie J; Wang J; Zeng R; Zhou F; Xie Y Front Med (Lausanne); 2022; 9():925661. PubMed ID: 35872794 [TBL] [Abstract][Full Text] [Related]
25. Exploration of Potential Roles of m5C-Related Regulators in Colon Adenocarcinoma Prognosis. Huang Y; Huang C; Jiang X; Yan Y; Zhuang K; Liu F; Li P; Wen Y Front Genet; 2022; 13():816173. PubMed ID: 35281843 [No Abstract] [Full Text] [Related]
26. A Prognostic Model for Colon Adenocarcinoma Patients Based on Ten Amino Acid Metabolism Related Genes. Ren Y; He S; Feng S; Yang W Front Public Health; 2022; 10():916364. PubMed ID: 35712285 [TBL] [Abstract][Full Text] [Related]
27. In silico development and clinical validation of novel 8 gene signature based on lipid metabolism related genes in colon adenocarcinoma. Jiang C; Liu Y; Wen S; Xu C; Gu L Pharmacol Res; 2021 Jul; 169():105644. PubMed ID: 33940186 [TBL] [Abstract][Full Text] [Related]
28. A novel enterocyte-related 4-gene signature for predicting prognosis in colon adenocarcinoma. Cheng X; Wei Y; Fu Y; Li J; Han L Front Immunol; 2022; 13():1052182. PubMed ID: 36532007 [TBL] [Abstract][Full Text] [Related]
29. Transient receptor potential channels as predictive marker and potential indicator of chemoresistance in colon cancer. Hu W; Wartmann T; Strecker M; Perrakis A; Croner R; Szallasi A; Shi W; Kahlert UD Oncol Res; 2023; 32(1):227-239. PubMed ID: 38188686 [TBL] [Abstract][Full Text] [Related]
30. Lactate Metabolism-Associated lncRNA Pairs: A Prognostic Signature to Reveal the Immunological Landscape and Mediate Therapeutic Response in Patients With Colon Adenocarcinoma. Xiao J; Wang X; Liu Y; Liu X; Yi J; Hu J Front Immunol; 2022; 13():881359. PubMed ID: 35911752 [TBL] [Abstract][Full Text] [Related]
31. Development of a 5-mRNAsi-related gene signature to predict the prognosis of colon adenocarcinoma. Huang H; Lu L; Li Y; Chen X; Li M; Yang M; Huang X PeerJ; 2023; 11():e16477. PubMed ID: 38025763 [TBL] [Abstract][Full Text] [Related]
32. Genome‑scale analysis to identify potential prognostic microRNA biomarkers for predicting overall survival in patients with colon adenocarcinoma. Wei HT; Guo EN; Liao XW; Chen LS; Wang JL; Ni M; Liang C Oncol Rep; 2018 Oct; 40(4):1947-1958. PubMed ID: 30066920 [TBL] [Abstract][Full Text] [Related]
33. Circadian Clock Genes Are Correlated with Prognosis and Immune Cell Infiltration in Colon Adenocarcinoma. He A; Huang Z; Zhang R; Lu H; Wang J; Cao J; Feng Q Comput Math Methods Med; 2022; 2022():1709918. PubMed ID: 35116071 [TBL] [Abstract][Full Text] [Related]
34. Developing a prognosis and chemotherapy evaluating model for colon adenocarcinoma based on mitotic catastrophe-related genes. Liu Y; Zhao Y; Zhang S; Rong S; He S; Hua L; Wang X; Chen H Sci Rep; 2024 Jan; 14(1):1655. PubMed ID: 38238555 [TBL] [Abstract][Full Text] [Related]
35. Identification of the six-hormone secretion-related gene signature as a prognostic biomarker for colon adenocarcinoma. Jia X; Zhang T; Lv X; Du H; Sun Y; Guan Y Cancer Biomark; 2023; 38(4):523-535. PubMed ID: 38143338 [TBL] [Abstract][Full Text] [Related]
36. Diagnostic and prognostic values of integrin α subfamily mRNA expression in colon adenocarcinoma. Gong YZ; Ruan GT; Liao XW; Wang XK; Liao C; Wang S; Gao F Oncol Rep; 2019 Sep; 42(3):923-936. PubMed ID: 31322253 [TBL] [Abstract][Full Text] [Related]
37. An epithelial-mesenchymal transition-related mRNA signature associated with the prognosis, immune infiltration and therapeutic response of colon adenocarcinoma. Zhang Y; Li Y; Zuo Z; Li T; An Y; Zhang W Pathol Oncol Res; 2023; 29():1611016. PubMed ID: 36910014 [No Abstract] [Full Text] [Related]
38. INHBA is a prognostic predictor for patients with colon adenocarcinoma. Li X; Yu W; Liang C; Xu Y; Zhang M; Ding X; Cai X BMC Cancer; 2020 Apr; 20(1):305. PubMed ID: 32293338 [TBL] [Abstract][Full Text] [Related]
39. Identification prognosis-associated immune genes in colon adenocarcinoma. Miao Y; Wang J; Ma X; Yang Y; Mi D Biosci Rep; 2020 Nov; 40(11):. PubMed ID: 33140821 [TBL] [Abstract][Full Text] [Related]
40. Weighted Gene Co-expression Network Analysis Identified a Novel Thirteen-Gene Signature Associated With Progression, Prognosis, and Immune Microenvironment of Colon Adenocarcinoma Patients. Zhang C; Zhao Z; Liu H; Yao S; Zhao D Front Genet; 2021; 12():657658. PubMed ID: 34322151 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]